Brunn Carsten 4
4 · Cartesian Therapeutics, Inc. · Filed Nov 15, 2023
Insider Transaction Report
Form 4
Brunn Carsten
DirectorPresident and CEO
Transactions
- Disposition to Issuer
Common Stock
2023-11-13$2.06/sh−55,000$113,300→ 728,081 total - Disposition to Issuer
Common Stock
2023-11-13$2.06/sh−13,600$28,016→ 714,481 total - Disposition to Issuer
Common Stock
2023-11-13$2.06/sh−169,725$349,634→ 544,756 total - Disposition to Issuer
Common Stock
2023-11-13$2.06/sh−282,800$582,568→ 261,956 total - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13−1,000,000→ 0 totalExercise: $6.03Exp: 2028-11-30→ Common Stock (1,000,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13−330,000→ 0 totalExercise: $2.20Exp: 2029-02-24→ Common Stock (330,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13$0.31/sh−400,000$124,000→ 0 totalExercise: $1.75Exp: 2029-10-06→ Common Stock (400,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13−600,000→ 0 totalExercise: $2.30Exp: 2030-01-01→ Common Stock (600,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13−75,000→ 0 totalExercise: $2.84Exp: 2030-06-30→ Common Stock (75,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13−670,000→ 0 totalExercise: $2.99Exp: 2031-01-03→ Common Stock (670,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13−163,000→ 0 totalExercise: $4.32Exp: 2031-09-23→ Common Stock (163,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13−1,056,100→ 0 totalExercise: $3.31Exp: 2032-01-02→ Common Stock (1,056,100 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13$0.93/sh−1,275,000$1,185,750→ 0 totalExercise: $1.13Exp: 2033-01-01→ Common Stock (1,275,000 underlying)
Footnotes (13)
- [F1]This unvested restricted stock, which was granted on January 4, 2021, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc., in exchange for $113,300, representing $2.06 per share, the Cash-out Amount as applied in the Merger.
- [F10]This option, which provided for vesting as to 25% of the shares on January 4, 2022 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
- [F11]This option, which provided for vesting as to 25% of the shares on September 24, 2022 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
- [F12]This option, which provided for vesting as to 25% of the shares on January 3, 2023 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
- [F13]This option, which provided for vesting as to 25% of the shares on January 2, 2024 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger, in exchange for a cash payment of $1,185,750, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.
- [F2]This unvested restricted stock, which was granted on September 24, 2021, was canceled in the Merger, in exchange for $28,016, representing $2.06 per share, the Cash-out Amount as applied in the Merger.
- [F3]This unvested restricted stock, which was granted on January 3, 2022, was canceled in the Merger, in exchange for $349,633.50, representing $2.06 per share, the Cash-out Amount as applied in the Merger.
- [F4]This unvested restricted stock, which was granted on January 2, 2023, was canceled in the Merger, in exchange for $582,568, representing $2.06 per share, the Cash-out Amount as applied in the Merger.
- [F5]This option, which provided for vesting as to 25% of the shares on December 1, 2019 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
- [F6]This option, which provided for vesting as to 25% of the shares on February 25, 2020 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
- [F7]This option, which provided for vesting as to 50% of the shares on October 7, 2020 and the remaining 50% of the shares on October 7, 2021, was canceled in the Merger, in exchange for a cash payment of $124,000, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.
- [F8]This option, which provided for vesting as to 25% of the shares on January 2, 2021 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
- [F9]This option, which provided for vesting as to 25% of the shares on July 1, 2021 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.